Evidence map›Paper›PMID 29325523›Full record

ArticleBMC medical genetics2018

Fanconi anemia with sun-sensitivity caused by a Xeroderma pigmentosum-associated missense mutation in XPF.

Isabell Popp, Maqsood Punekar, Nick Telford, Stavros Stivaros, Kate Chandler, Meenakshi Minnis, Anna Castleton, Claire Higham, Louise Hopewell, D Gareth Evans and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Isabell PoppDepartment of Human Genetics, Biozentrum, University of Wurzburg, Am Hubland, 97074, Wurzburg, Germany.
Maqsood PunekarLancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Nick TelfordOncology Cytogenetics, The Christie NHS Foundation Trust, Manchester, UK.
Stavros StivarosInstitute of Population Health, Centre for Imaging Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK.
Kate ChandlerManchester Academic Health Science Centre, Manchester, UK.
Meenakshi MinnisManchester Academic Health Science Centre, Manchester, UK.
Anna CastletonDepartment of Paediatric and Adolescent Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Claire HighamDepartment of Paediatric and Adolescent Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Louise HopewellDepartment of Paediatric and Adolescent Oncology, The Christie NHS Foundation Trust, Manchester, UK.
D Gareth EvansDepartment of Genetic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, UK.
Anja RaamsDepartment of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Arjan F TheilDepartment of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Stefan MeyerManchester Academic Health Science Centre, Manchester, UK. stefan.meyer@manchester.ac.uk.ORCID 0000-0002-2283-3690
Detlev SchindlerDepartment of Human Genetics, Biozentrum, University of Wurzburg, Am Hubland, 97074, Wurzburg, Germany. schindler@biozentrum.uni-wuerzburg.de.
Manchester Academic Health Science Centre · GBThe Christie NHS Foundation Trust · GBErasmus MC · NLUniversity of Würzburg · DELancashire Teaching Hospitals NHS Foundation Trust · GBSt Mary's Hospital · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFanconi anemia (FA) is an inherited genomic instability disorder with congenital and developmental abnormalities, bone marrow failure and predisposition to cancer early in life, and cellular sensitivity to DNA interstrand crosslinks. CASE PRESENTATION: A fifty-one-year old female patient, initially diagnosed with FA in childhood on the basis of classic features and increased chromosomal breakage, and remarkable sun-sensitivity is described. She only ever had mild haematological abnormalities and no history of malignancy. To identify and characterise the genetic defect in this lady, who is one of the oldest reported FA patients, we used whole-exome sequencing for identification of causative mutations, and functionally characterized the cellular phenotype. Detection of the novel splice site mutation c.793-2A > G and the previously described missense mutation c.1765C > T (p.Arg589Trp) in XPF/ERCC4/FANCQ assign her as the third individual of complementation group FA-Q. Ectopic expression of wildtype, but not mutant, XPF/ERCC4/FANCQ, in patient-derived fibroblasts rescued cellular resistance to DNA interstrand-crosslinking agents. Patient derived FA-Q cells showed impaired nuclear excision repair capacity. However, mutated XPF/ERCC4/FANCQ protein in our patient's cells, as in the two other patients with FA-Q, was detectable on chromatin, in contrast to XP-F cells, where missense-mutant protein failed to properly translocate to the nucleus.

conclusionsPatients with FA characteristics and UV sensitivity should be tested for mutations in XPF/ERCC4/FANCQ. The missense mutation p.Arg589Trp was previously detected in patients diagnosed with Xeroderma pigmentosum or Cockayne syndrome. Hence, phenotypic manifestations associated with this XPF/ERCC4/ FANCQ mutation are highly variable.

Indexed as

Mutation, MissenseAmino Acid SequenceCell LineCell Line, TumorDNA-Binding ProteinsDNA DamageDNA RepairFanconi AnemiaFemaleFibroblastsGenetic Association StudiesGenetic Predisposition to DiseaseHumansMiddle AgedPhotosensitivity DisordersSolar SystemDNA-Binding Proteinsxeroderma pigmentosum group F proteinDNA repairERCC4Fanconi anemiaFANCQUV sensitivityXPF

Identifiers

PMID29325523
PMCPMC5765604
OpenAlexW2782551979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.